Swedish Orphan Biovitrum AB (SOBI) Stock Statistics & Valuation Metrics

Swedish Orphan Biovitrum AB has a market cap or net worth of kr102.09B. The enterprise value is kr112.75B.

Swedish Orphan Biovitrum AB has 356,000,060 shares outstanding. The number of shares has decreased by -2.65% in one year.

Swedish Orphan Biovitrum AB’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.40%.

The current PE Ratio of Swedish Orphan Biovitrum AB is 27.92. Swedish Orphan Biovitrum AB’s PEG ratio is 0.53.

In the last 12 months, Swedish Orphan Biovitrum AB had revenue of 26.03B and earned 3.88B in profits. Earnings per share was 11.37.

In the last 12 months, operating cash flow was 7.62B and capital expenditures -2.29B, giving a free cash flow of 5.33B billion.

Swedish Orphan Biovitrum AB pays an annual dividend of ―, resulting in a dividend yield of ―

Swedish Orphan Biovitrum AB upcoming earnings date is Jul 16, 2025, TBA Not Confirmed.

Swedish Orphan Biovitrum AB as a current ratio of 1.04, with Debt / Equity ratio of 35.92%

In the past 12 months, Swedish Orphan Biovitrum AB has paid 528.00M in taxes.

Swedish Orphan Biovitrum AB EV to EBITDA ratio is 13.33, with an EV/FCF ratio of 28.30.

Swedish Orphan Biovitrum AB has kr997.00M in cash and marketable securities with kr14.02B in debt, giving a net cash position of kr13.02B billion.

Gross margin is 74.93%, with operating margin of 21.61%, and net profit margin of 14.93%.

The average price target for Swedish Orphan Biovitrum AB is kr350.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy